This Week in Washington IP: PPAC’s 2020 Annual Report, Biological R&D Within the U.S. Department of Energy and COVID-19’s Impact on University Research
This week in Washington IP news, Congress returns to work after August recess. Hearings at the House of Representatives focus on various topics relevant to R&D, including legislative sessions exploring bills directing federal support of research programs, the impacts of the COVID-19 pandemic on university-led research programs and Department of Energy biomedical research programs for better understanding coronavirus. The U.S. Patent and Trademark Office hosts training sessions on maintaining registered trademarks and filing international patent applications, while the agency’s Patent Public Advisory Committee (PPAC) meets Tuesday to discuss findings from that committee’s 2020 annual report. Elsewhere, the Center for Strategic & International Studies discusses the potential of synthetic biology research to contribute to economic recovery in the wake of COVID-19, and the Information Technology & Innovation Foundation explores useful changes to the federal government’s portfolio of research, development and demonstration (RD&D) programs especially as they relate to clean energy innovation.